Literature DB >> 2920745

High dose intravenous methylprednisolone for Kassabach-Merritt syndrome.

S Ozsoylu1, G Irken, A Gürgey.   

Abstract

Kassabach-Merritt syndrome involving the sternum in a 2-month-old child is described. Treatment with high dose intravenous methylprednisolone resulted in normalization of the platelet count and disappearance of haemangioma.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2920745     DOI： 10.1007/BF00595897

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  15 in total

1.  Reversal of coagulopathy in Kasabach-Merritt syndrome with tranexamic acid.

Authors:  A J Bell; M Chisholm; M Hickton
Journal:  Scand J Haematol       Date:  1986-09

2.  High-dose intravenous methylprednisolone for refractory or resistant Diamond-Blackfan anemia.

Authors:  S Ozseylu
Journal:  Eur J Haematol       Date:  1987-08       Impact factor: 2.997

3.  Cyclophosphamide therapy in life-threatening vascular tumors.

Authors:  C H Hurvitz; A L Alkalay; L Sloninsky; M Kallus; J J Pomerance
Journal:  J Pediatr       Date:  1986-08       Impact factor: 4.406

4.  Chronic defibrination syndrome due to a giant hemangioma associated with microangiopathic hemolytic anemia.

Authors:  S Inceman; Y Tangũn
Journal:  Am J Med       Date:  1969-06       Impact factor: 4.965

5.  Treatment of severe coagulopathy in the Kasabach-Merritt syndrome with aminocaproic acid and cryoprecipitate.

Authors:  R P Warrell; S J Kempin
Journal:  N Engl J Med       Date:  1985-08-01       Impact factor: 91.245

6.  High dose intravenous methylprednisolone in treatment of recessive osteopetrosis.

Authors:  S Ozsoylu
Journal:  Arch Dis Child       Date:  1987-02       Impact factor: 3.791

7.  High-dose intravenous methylprednisolone for acute childhood idiopathic thrombocytopenic purpura.

Authors:  S Ozsoylu; G Irken; A Karabent
Journal:  Eur J Haematol       Date:  1989-05       Impact factor: 2.997

8.  Coagulation defects and giant cavernous hemangioma. A case study in infancy.

Authors:  S J Wacksman; H C Flessa; H I Glueck; J J Will
Journal:  Am J Dis Child       Date:  1966-01

9.  High-dose intravenous corticosteroid for a patient with Diamond-Blackfan syndrome refractory to classical prednisone treatment.

Authors:  S Ozsoylu
Journal:  Acta Haematol       Date:  1984       Impact factor: 2.195

10.  High dose intravenous glucocorticoid in the treatment of childhood acquired aplastic anaemia.

Authors:  S Ozsoylu; T Coşkun; S Minassazi
Journal:  Scand J Haematol       Date:  1984-09
View more
  10 in total

1.  Megadose methylprednisolone for Kasabach-Merritt syndrome.

Authors:  Şinasi Özsoylu
Journal:  Eur J Pediatr       Date:  2003-05-14       Impact factor: 3.183

2.  Megadose methylprednisolone for diffuse infantile haemangiomatosis.

Authors:  S Ozsoylu
Journal:  Eur J Pediatr       Date:  1992-05       Impact factor: 3.183

3.  Anesthesia and perioperative management for Kasabach-Merritt syndrome--report of a case.

Authors:  H Horikawa; T Tada; O Honda
Journal:  J Anesth       Date:  1992-10       Impact factor: 2.078

4.  Interferon alpha-2a therapy of consumptive coagulopathy in Kasabach-Merritt syndrome.

Authors:  C Klein; M Hauser; H B Hadorn
Journal:  Eur J Pediatr       Date:  1992-12       Impact factor: 3.183

5.  Megadose methylprednisolone for Kasabach-Merritt syndrome.

Authors:  S Ozsoylu
Journal:  Eur J Pediatr       Date:  1996-02       Impact factor: 3.183

6.  Kasabach-merritt syndrome arising from tufted angioma successfully treated with systemic corticosteroid.

Authors:  Taegyun Kim; Mi Ryung Roh; Soohyun Cho; Kee Yang Chung
Journal:  Ann Dermatol       Date:  2010-11-05       Impact factor: 1.444

7.  Interferon-alpha-2a for the treatment of complex hemangiomas of infancy and childhood.

Authors:  R R Ricketts; R M Hatley; B J Corden; H Sabio; C G Howell
Journal:  Ann Surg       Date:  1994-06       Impact factor: 12.969

8.  About the treatment of kasabach-merritt syndrome.

Authors:  Sinasi Ozsoylu
Journal:  Turk J Haematol       Date:  2013-03-05       Impact factor: 1.831

9.  Megadose Methylprednisolone (MDMP) for Hemangiomatosis.

Authors:  Sinasi Ozsoylu
Journal:  Turk J Haematol       Date:  2012-12-05       Impact factor: 1.831

10.  Megadose Methylprednisolone (MDMP) Treatment in a Patient with Autoimmune Hemolytic Anemia (AIHA) Resistant to Conventional Corticosteroid Administration: A Case Report.

Authors:  Sinasi Ozsoylu; Henriette Wa Berenschot
Journal:  Turk J Haematol       Date:  2013-06-05       Impact factor: 1.831
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.